NDC Sample Clauses

POPULAR SAMPLE Copied 1 times
NDC. Purchaser shall take any and all action, as expeditiously as possible (but in no event later than six months after the Closing), necessary to change the National Drug Code ("NDC") number for each Product and to apply such new NDC number to each Product sold, however, that the foregoing shall not apply to the Inventory.
View Source
NDC. Buyer shall use its reasonable best efforts to obtain, no later than 90 days following the Closing Date, its own NDC for the Product and have in place all resources such that sales of the Product in the Territory can be accomplished under the NDCs of Buyer; provided, that Buyer shall use its commercially reasonable efforts to obtain its own NDC for the Product and have in place such resources as of the Closing Date. Following the Closing Date, except as otherwise provided in the Transitional Services Agreement, neither Seller, nor any of its respective Affiliates shall distribute or sell any Product in the Territory labeled with Seller’s NDC.
View SourceView Similar (2)
NDC. Promptly following the Execution Date, but in any event no later than six months following the Closing Date, Buyer shall obtain its own NDC for the Product and shall have in place, all resources such that sales of the Product in the Territory can be accomplished under the NDCs of Buyer. Following the TSA End Date, neither Seller, nor any of its respective Affiliates or its or its Affiliates’, licensees or sublicensees shall distribute or sell any Product in the Territory labeled with Seller’s NDC.
View SourceView Similar (2)
NDC. NDC represents, warrants, and covenants (for itself, and in the case of Section 15.1(b), for and on behalf of NDCHIS) to Medscape as follows: (a) NDC has full authority to enter into this Agreement, and the person signing on behalf of NDC is authorized to sign on NDC's behalf; (b) the license between NDC Health Information Services (Arizona) Inc., a wholly-owned subsidiary of NDC ("NDCHIS"), and the American Medical Association, dated as of January 1, 1998 (the "AMA License")(a true, complete and accurate copy of which has been previously provided to Medscape) is in full force and effect. Neither NDCHIS nor NDC is in breach or default, and upon giving effect to the AMA Sublicense, will not be in breach or default, of any of the material terms and conditions thereof. Upon receipt of AMA's consent to the terms of the AMA Sublicense (if required), NDCHIS will have the right and authority under the terms of the AMA License to sublicense its rights under the AMA License to Medscape pursuant to the terms of the AMA Sublicense. The terms of the AMA Sublicense do and shall comply in all respect with the terms or conditions specified with respect thereto in the AMA License, and upon execution of the AMA Sublicense by Medscape and NDCHIS, Medscape will be a duly authorized sublicensee of NDCHIS, in accordance with and subject to the terms thereof and the AMA License. (c) NDC is the owner, or has the right to use, license, reproduce, and distribute all materials and methodologies, including computer programs, used, licensed or supplied by NDC to Medscape; (d) NDC has the right to authorize Medscape to use, all materials supplied or licensed by NDC to Medscape pursuant to this Agreement;
View SourceView Similar (2)
NDC. Endo shall at all times during the term of this Agreement maintain (or otherwise not change the status of) the National Drug Code(s) in respect of the Opana® ER Product until the end of the Exclusivity Period, unless otherwise directed by the FDA.
View Source

Related to NDC

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • PRODUCT MANUFACTURER'S SUPPLIERS Only those dealers/distributors listed by the manufacturer will be considered authorized to act on behalf of the Product Manufacturer.

  • Distributors In addition to direct sales to Clients, Supplier grants Accenture: (i) the right to resell Products and Services to a third-party

  • Country and Territory Names The country and territory names (including their IDN variants, where applicable) contained in the following internationally recognized lists shall be withheld from registration or allocated to Registry Operator at All Levels: the short form (in English) of all country and territory names contained on the ISO 3166-1 list, as updated from time to time, including the European Union, which is exceptionally reserved on the ISO 3166-1 list, and its scope extended in August 1999 to any application needing to represent the name European Union <▇▇▇▇://▇▇▇.▇▇▇.▇▇▇/iso/support/country_codes/iso_3166_code_lists/iso-3166-1_decoding_table.htm>; the United Nations Group of Experts on Geographical Names, Technical Reference Manual for the Standardization of Geographical Names, Part III Names of Countries of the World; and the list of United Nations member states in 6 official United Nations languages prepared by the Working Group on Country Names of the United Nations Conference on the Standardization of Geographical Names; provided, that the reservation of specific country and territory names (including their IDN variants according to the registry operator IDN registration policy, where applicable) may be released to the extent that Registry Operator reaches agreement with the applicable government(s). Registry Operator must not activate such names in the DNS; provided, that Registry Operator may propose the release of these reservations, subject to review by ICANN’s Governmental Advisory Committee and approval by ICANN. Upon conclusion of Registry Operator’s designation as operator of the registry for the TLD, all such names that remain withheld from registration or allocated to Registry Operator shall be transferred as specified by ICANN. Registry Operator may self-allocate and renew such names without use of an ICANN accredited registrar, which will not be considered Transactions for purposes of Section 6.1 of the Agreement.

  • Prescription Drugs and Diabetic Equipment or Supplies Biological products for allergen immunotherapy and vaccinations. • Blood fractions. • Compound prescription drugs that are not made up of at least one legend drug. • Bulk powders and chemicals used in compound prescriptions that are not FDA approved, are not covered unless listed on our formulary. • Prescription drugs prescribed or dispensed outside of our dispensing guidelines. • Prescription drugs ordered or prescribed based solely on online questionnaires, telephonic interviews, surveys, emails, or any other marketing solicitation methods, whether alone or in combination. • Prescription drugs that have not proven effective according to the FDA. • Prescription drugs used for cosmetic purposes. • Prescription drugs purchased from a non-designated pharmacy, if a pharmacy has been designated for you through the Pharmacy Home Assignment program. • Experimental prescription drugs including those placed on notice of opportunity hearing status by the Federal Drug Efficacy Study Implementation (DESI). • Prescription drugs provided to you that are not dispensed by a network pharmacy or covered under your medical plan. • Prescription drugs and diabetic equipment and supplies purchased at a non-network pharmacy unless indicated as covered in the Summary of Pharmacy Benefits. • Prescription drug related medical supplies except for diabetic, regardless of the reason prescribed, the intended use, or medical necessity. Examples include, but are not limited to, alcohol pads, bandages, wraps or pill holders. • Off-label use of prescription drugs except as described in Experimental or Investigational Services in Section 3; • Prescribed weight-loss drugs. • Replacement of prescription drugs resulting from a lost, stolen, broken or destroyed prescription order or refill. • Therapeutic devices and appliances, including hypodermic needles and syringes except when used to administer insulin. • Prescription drugs, therapeutic equivalents, or any other pharmaceuticals used to treat sexual dysfunctions. • Vitamins, unless specifically listed as a covered healthcare service. • A prescription drug refill greater than the refill number authorized by your physician, more than a year from the date of the original prescription, or limited by law. • Long acting opioids and other controlled substances, nicotine replacement therapy, and specialty prescription drugs when purchased from a mail order pharmacy. • Prescription drugs and specialty prescription drugs when the required prescription drug preauthorization is not obtained. • Certain prescription drugs that have an over-the-counter (OTC) equivalent. • Prescriptions filled through an internet pharmacy that is not a verified internet pharmacy practice site certified by the National Association of Boards of Pharmacy. • Illegal drugs, including medical marijuana, which are dispensed in violation of state and/or federal law. • Services of a nurse's aide. • Services of a private duty nurse: o when the primary duties are limited to bathing, feeding, exercising, homemaking, giving oral medications or acting as companion or sitter; o after the caregiver or patient have demonstrated the ability to carry out the plan of care; o provided outside the home. Examples include at school, or in a nursing or assisted living facility; o that are duplication or overlap of services. Examples include when a person is receiving hospice care services or for the same hours of a skilled nursing home care visit; o that are for observation only; and o provided as part-time/intermittent and not continuous care. • Maintenance care when the condition has stabilized including routine ostomy care or tube feeding administration or if the anticipated need is indefinite. • Twenty-four (24) hour private duty nursing care for a person without an available caregiver in the home. • Respite care (e.g., care during a caregiver vacation) or private duty nursing so that the caregiver may attend work or school. • Abdominoplasty. • Brow ptosis surgery. • Cervicoplasty. • Chemical exfoliations, peels, abrasions, dermabrasions, or planing for acne, scarring, wrinkling, sun damage or other benign conditions. • Correction of variations in normal anatomy including augmentation mammoplasty, mastopexy, and correction of congenital breast asymmetry. • Dermabrasion. • Ear piercing or repair of a torn earlobe. • Excision of excess skin or subcutaneous tissue except for panniculectomy. • Genioplasty. • Hair transplants. • Hair removal including electrolysis epilation, unless in relation to gender reassignment services or skin grafting. • Inverted nipple surgery. • Laser treatment for acne and acne scars. • Osteoplasty - facial bone reduction. • Otoplasty. • Procedures to correct visual acuity including but not limited to cornea surgery or lens implants. • Removal of asymptomatic benign skin lesions. • Repeated cauterizations or electrofulguration methods used to remove growths on the skin. • Rhinoplasty.